DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve

NCT06572215 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2026-04-01

No results posted yet for this study

Summary

This is a feasibility study to assess new, more practical ways of measuring renal reserve.

Conditions

  • Chronic Kidney Diseases

Interventions

DRUG

Dapagliflozin

On Day 3 to 16, participants will take 10mg dapaglifozin (SGLT-2 inhibitor) orally once daily.

Sponsors & Collaborators

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-14
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06572215 on ClinicalTrials.gov